33 results
Hyperkalemia Treatment Options
Stabilize cardiac membrane:
 • IV Calcium (peaks 5-10 minutes)
Decrease potassium concentration:
 • IV Fluids
Shift
Hyperkalemia Treatment ... membrane: • IV ... concentration: • IV ... #management #potassium ... #nephrology
Ischemic Stroke - Blood Pressure Management
 • No tPA  < 220 / 120 (permissive hypertension)
Blood Pressure Management ... tPA <180/110 • IV ... #hypertension #Management ... #treatment #neurology ... #medications
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
and Management ... Etiology: • Medications ... STOP offending medications ... #Treatment #potassium ... #nephrology #K
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... PO (or 400 mg IV ... Enteric #Bacterial #IDSA ... #Prevention #Treatment ... #management #opportunistic
Acute ED Migraine Therapy and Preventative Therapy Algorithm:
Acute migraine
 • IV NS IL bolus then infusion
20 mg/min -> Neurology ... Preventative Medications ... #Migraine #management ... #algorithm #treatment ... #prophylaxis #neurology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... to 5 mg/kg/day IV ... Penicilliosis #IDSA ... #Prevention #Treatment ... #management #opportunistic
Emergency Treatment Algorithm for Convulsive Status Epilepticus
1. ABCDEFG (ABC's and Don't Ever Forget the Glucose)
2. Airway:
Emergency Treatment ... Refractory medications ... #Epilepticus #Treatment ... #Algorithm #Management ... #Neurology #Pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... for effective treatment ... 400 mg) PO or IV ... candida #mucosal #IDSA ... #management #opportunistic
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... Leishmaniasis #Prevention #Treatment ... #management #opportunistic
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Diagnosis and Management ... (IDSA 2021): ... Bezlotoxumab 10 mg/kg IV ... /severe CDI IDSA ... #treatment #infectiousdiseases